Suicide prodrugs activated by thymidylate synthase: rationale for treatment and noninvasive imaging of tumors with deoxyuridine analogues.
Suicide prodrugs activated by thymidylate synthase: rationale for treatment and noninvasive imaging of tumors with deoxyuridine analogues.
复制标题
胸苷酸合成酶激活的自杀前药：用脱氧尿苷类似物治疗肿瘤和无创成像的基本原理。
作者：
J. Collins;R. Klecker;A. Katki
Most tumors are resistant to therapy by thymidylate synthase (TS) inhibitors due to their high levels of TS. Instead of inhibiting TS, we hypothesized that it was possible to use this enzyme to activate suicide prodrugs (deoxyuridine analogues) to more toxic species (thymidine analogues). Tumors with high levels of TS could be particularly sensitive to deoxyuridine analogues because they would be more efficient in producing the toxic methylated species. Furthermore, the accumulation of methylated species within tumors could be visualized externally if a tracer dose of the deoxyuridine analogue was tagged with an isotope, preferably a positron emitter, such as 18F. Higher accumulation of isotope indicates higher activity of TS and lower sensitivity of the tumor to TS inhibitors, but perhaps more sensitivity to therapy with deoxyuridine analogues as suicide prodrugs. 2'-F-ara-deoxyuridine (FAU) was used as a prototype to demonstrate these concepts experimentally. FAU readily entered cells and was phosphorylated, methylated, and subsequently incorporated into cellular DNA. Among different cell lines, FAU produced varying degrees of growth inhibition. Greater DNA incorporation (e.g., for CEM and U-937 cells) was reflected as increased toxicity. FAU produced less DNA incorporation in Raji or L1210 cells, and growth rate was minimally decreased. As the first demonstration that cells with high levels of TS activity can be more vulnerable to therapy than cells with low TS activity, this preliminary work suggests a new therapeutic approach for common human tumors that were previously resistant. Furthermore, it appears that the TS activity of tumors could be noninvasively imaged in situ by tracer doses of [18F]FAU and that this phenotypic information could guide patient therapy.
登录
查看更多内容
2-氟-1-β-D-阿拉伯呋喃糖基嘧啶在 HL-60 细胞中的细胞分化作用。
影响因子：
2.7
作者：
Kong,XB;Andreeff,M;Fanucchi,MP;Fox,JJ;Watanabe,KA;Vidal,P;Chou,TC
通讯作者：
Chou,TC
影响因子：
11.2
作者：
P. Johnston;H. Lenz;C. Leichman;K. Danenberg;C. Allegra;P. Danenberg;L. Leichman
通讯作者：
P. Johnston;H. Lenz;C. Leichman;K. Danenberg;C. Allegra;P. Danenberg;L. Leichman
通过改进的氚释放测定改进了胸苷酸合成酶活性的测量。
影响因子：
--
作者：
Armstrong,RD;Diasio,RB
通讯作者：
Diasio,RB
1-(2-脱氧-2-氟-β-L-阿拉伯呋喃糖基)-5-甲基尿嘧啶 5-三磷酸对 Epstein-Barr 病毒和人类 DNA 聚合酶具有独特的抑制作用。
影响因子：
5.8
作者：
Kukhanova,M;Lin,ZY;Yas'co,M;Cheng,YC
通讯作者：
Cheng,YC